Oncozenge AB (ONCOZ) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Oncozenge AB (ONCOZ) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr263.00K. See free cash flow generation of Oncozenge AB to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr263.00K
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Oncozenge AB (None–None)
Year-by-year capital reinvestment analysis for Oncozenge AB. See ONCOZ financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow